GVK Bio Names New Senior Vice President For Discovery Chemistry

Prior to joining GVK Bio, Dr Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and drug discovery.

During the course of his time at Wyeth, he established a core parallel synthesis group and an integrated medicinal chemistry group working in all phases of drug discovery. His responsibilities included the identification of leads and development candidates across multiple therapeutic areas and leading a department across several research sites.

The chemistry group worked closely with screening sciences, computational chemistry, X-ray crystallography, and drug safety and metabolism groups to identify optimal development candidates. While at Wyeth, he initiated and managed a large chemistry partnership with GVK Bio.

GV Sanjay Reddy, managing director of GVK Biosciences, said: “I am pleased to welcome John on board. As senior vice president of discovery chemistry, John will lead the medicinal chemistry efforts of various collaborative research programs and will play a key role in guiding the company’s future collaborative research efforts.”

JB Gupta, senior vice president of collaborative research & biology at said: “GVK Bio is making significant investments to further strengthen its collaborative research capabilities. GVK Biosciences is working on several collaborative research projects with Big Pharma and we look forward to John’s rich experience in medicinal chemistry and discovery to guide these programs.”